| Literature DB >> 28238105 |
Yanjie Zhang1, Bo Huang2, Hui-Yun Wang3,4,5, Augustus Chang5, X F Steven Zheng6,7,8.
Abstract
Mechanistic target of rapamycin (mTOR) is a conserved serine/threonine kinase that plays a critical role in the control of cellular growth and metabolism. Hyperactivation of mTOR pathway is common in human cancers, driving uncontrolled proliferation. MicroRNA (miRNA) is a class of short noncoding RNAs that regulate the expression of a wide variety of genes. Deregulation of miRNAs is a hallmark of cancer. Recent studies have revealed interplays between miRNAs and the mTOR pathway during cancer development. Such interactions appear to provide a fine-tuning of various cellular functions and contribute qualitatively to the behavior of cancer. Here we provide an overview of current knowledge regarding the reciprocal relationship between miRNAs and mTOR pathway: regulation of mTOR signaling by miRNAs and control of miRNA biogenesis by mTOR. Further research in this area may prove important for the diagnosis and therapy of human cancer.Entities:
Keywords: Biomarker; Cancer; Cell signaling pathway; MicroRNA; mTOR
Mesh:
Substances:
Year: 2017 PMID: 28238105 PMCID: PMC5482757 DOI: 10.1007/s00018-017-2485-1
Source DB: PubMed Journal: Cell Mol Life Sci ISSN: 1420-682X Impact factor: 9.261